GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Operating Cash Flow per Share

Organon (MEX:OGN) Operating Cash Flow per Share : MXN65.35 (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Operating Cash Flow per Share?

Organon's operating cash flow per share for the three months ended in Sep. 2024 was MXN10.69. Organon's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN65.35.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Organon was 40.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -28.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Organon's Operating Cash Flow per Share or its related term are showing as below:

MEX:OGN' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -32.5   Med: -28.8   Max: -12.8
Current: -28.8

During the past 6 years, Organon's highest 3-Year average Operating Cash Flow per Share Growth Rate was -12.80% per year. The lowest was -32.50% per year. And the median was -28.80% per year.

MEX:OGN's 3-Year OCF Growth Rate is ranked worse than
84.52% of 788 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs MEX:OGN: -28.80

Organon Operating Cash Flow per Share Historical Data

The historical data trend for Organon's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Operating Cash Flow per Share Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial 206.16 171.86 198.37 65.56 52.92

Organon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.74 26.26 4.88 23.52 10.69

Competitive Comparison of Organon's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Organon's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organon's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Organon's Price-to-Operating-Cash-Flow falls into.



Organon Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Organon's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=13562.424/256.270
=52.92

Organon's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )=Cash Flow from Operations (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=2776.332/259.757
=10.69

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN65.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Organon's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Business Description

Industry
Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.